Keyword: Aranesp misbranding

News

U.S. Court Approves Amgen's $762 Million Payment in Drug Case

20.12.2012 - A federal judge on Wednesday approved a $762 million payment from Amgen, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once...

News

Amgen Pleads Guilty to Misbranding Charges, Will Pay $762 Million

18.12.2012 - Amgen pleaded guilty in a federal court in New York on Tuesday to misbranding its Aranesp anemia drug and agreed to pay $762 million in a civil settlement and criminal fines. The...